Regulatory TYKERB® Tablets PMS

Update Il y a 4 ans
Reference: NCT00975988

Woman and Man

Extract

Non-interventional, open-label, single group, multicentric post-marketing surveillance to monitor the safety and effectiveness of TYKERB® tablets administered in Korean patients according to the prescribing information TYKERB® is a registered trademark of the GlaxoSmithKline group of companies.


Inclusion criteria

  • Cancer

Links